Bacteriostatic Water 30ml
Bacteriostatic water 30ml. Bacteriostatic water 30 mL explained for laboratory research — uses, storage, shelf life, and documentation checks you can verify
A carton of research materials has just arrived. Before any powder is reconstituted, the receiving researcher checks the 30 mL bacteriostatic water vial, confirms that the label matches the packing slip, and asks a practical question: will this container support the planned withdrawal pattern, or will part of it be discarded when the in-use window closes? That question matters because vial size affects sample preparation, contamination control, stock rotation, and the records needed to defend a result during review.
For a laboratory handling repeated peptide, protein, or small-molecule preparations, the volume on the label is only the starting point. The preservative system, container integrity, storage conditions, first-puncture date, and batch documentation determine whether the vial is suitable for the workflow.
Why the 30 mL Vial Matters at the Bench
A batch preparation is scheduled for repeated small-volume draws. Before opening the container, the researcher needs to know whether a 30 mL multi-dose vial fits that schedule or will leave unused material at the end of its labeled in-use period. U.S. labeling identifies the 30 mL presentation as a multiple-dose vial intended for diluting or dissolving drugs for injection, subject to labeling and compatibility instructions (U.S. product labeling). In a research laboratory, it should therefore be managed as a controlled diluent source for documented sample preparation, not as an informal bottle of solvent.
Receiving checks establish whether the vial can enter that workflow. Confirm that the flip-top cap is seated, the crimp and stopper appear intact, and the solution is clear and free of visible particles. Compare the lot number, expiration date, formulation details, and manufacturer with the packing slip and quality records. Record the container identity before the first puncture. A mismatch belongs in the receiving record and should be resolved before bench use.
Estimate withdrawals before opening
A nominal 30 mL fill does not equal thirty usable 1 mL events. Syringe dead space, transfer losses, line priming, and the volume required for each preparation reduce the practical yield. Repeated 1 mL withdrawals may support roughly twenty to twenty-five withdrawals. Larger aliquots reduce that count. This is a planning estimate, not a release specification, so confirm it against the equipment and technique used by the laboratory.
Place the forecast beside the study schedule. Several compounds requiring small-volume preparation within a short project window may fit within one vial. Intermittent work creates a different risk: the container may remain in use until its discard date while only part of the planned volume is withdrawn. Opening a second vial can be appropriate when the schedule cannot be completed within the labeled period.
Practical rule: Treat the first puncture as the start of a documented clock. Record the date, technician, lot, and remaining volume before the vial returns to storage.
Each withdrawal also requires an auditable handling record. Note the preparation or batch identity, withdrawal volume, and any abnormal observation alongside the vial lot. The preservative supports the multi-dose design, but it does not replace aseptic technique or make a damaged or compromised container acceptable.
The 30 mL format consequently affects stock rotation and review readiness. A sound plan connects expected draws, discard timing, container identity, and the records needed to verify that each preparation came from the intended vial.
What Bacteriostatic Water Actually Is
Bacteriostatic Water for Injection, USP is sterile, nonpyrogenic water containing benzyl alcohol as a preservative. Major U.S. labels identify a formulation containing 0.9% benzyl alcohol, or 9 mg/mL, and describe 30 mL presentations as multiple-dose vials (Pfizer labeling). Other marketed presentations can differ. Pfizer Medical labeling identifies a 30 mL plastic flip-top format with 9 mg/mL benzyl alcohol, while a 20 mL fill in a 30 mL glass format uses 11 mg/mL, so the exact label must govern the laboratory record (DailyMed product labeling).
The word bacteriostatic describes growth inhibition, not sterilization. Benzyl alcohol helps suppress microbial growth after repeated withdrawals, but it doesn't repair a damaged closure, neutralize every contaminant, or guarantee that a vial remains suitable after poor handling. The water also isn't saline. Saline contains sodium chloride, while bacteriostatic water is a preserved water-for-injection product.
Sterile Water for Injection has a different risk profile because it lacks a preservative and is generally supplied for single-use preparation. A laboratory must therefore match the diluent to the compound, assay, compatibility requirements, and container design rather than choosing by volume alone. The compound research library can provide useful context for connecting diluent selection with the broader material under investigation, but the product label and study protocol remain controlling documents.
Bacteriostatic vs. Sterile Water for Injection
| Attribute | Bacteriostatic Water (30 mL) | Sterile Water for Injection |
|---|---|---|
| Basic composition | Sterile water with benzyl alcohol preservative | Sterile, non-preserved water |
| Container role | Multiple-dose diluent presentation | Single-use diluent presentation |
| Repeated access | Designed for repeated withdrawals under labeled handling conditions | Not selected for routine repeated access |
| Main laboratory question | Can the preservative system and in-use record support the planned workflow? | Can the full preparation be completed without retaining an opened container? |
| Compatibility | Must follow the instructions for the material being prepared | Must follow the instructions for the material being prepared |
Neonatal handling is a critical boundary. DailyMed labeling warns that benzyl alcohol has been associated with toxicity in neonates, which is one reason the product isn't interchangeable across all patient populations (DailyMed safety labeling). For laboratory work, the same principle translates into careful review of the protocol, material compatibility, and intended research context.
Approved Laboratory Uses for Reconstitution
In a research setting, bacteriostatic water 30ml is best understood as a sample-preparation diluent. It may be selected to dissolve or dilute lyophilized peptides, proteins, small molecules, and reference materials before transfer into assay buffers or working solutions. The exact suitability depends on the compound's instructions and the analytical method, because a preserved diluent can influence solubility, matrix composition, and downstream assay behavior.
The preparation sequence should begin with a calculation. The researcher determines the target concentration, checks the amount of material in the vial, and selects a diluent volume that fits the protocol. The calculation belongs in the batch record before the stopper is entered. That record should also identify the diluent lot, compound lot, target concentration, technician, and preparation date.
Keep sample preparation controlled
After the diluent is added according to the approved laboratory method, the material should be allowed to dissolve with gentle handling. Aggressive vortexing can create foaming and may complicate visual assessment, especially when the preparation contains a protein or peptide. A clear, particulate-free result is the expected visual checkpoint when the method calls for a clear solution. Persistent haze, unexpected color, or visible material should trigger quarantine and investigation rather than routine transfer.
A shared vial can support several preparation events, including:
- Serial dilution stocks: A controlled starting solution can support analytical dilution schemes when the protocol permits the chosen vehicle.
- Vehicle controls: The diluent itself can be included in an appropriate control design to distinguish vehicle effects from compound-related observations.
- Cell-culture additives: Hydration of a compatible additive may be possible when the method and material documentation specify water as suitable.
- Reference preparations: Analytical standards can be prepared when the solvent, concentration range, and stability requirements have been approved.
The 30 mL format is especially relevant where a laboratory performs repeated, small-volume withdrawals across a defined study window. The preservative system supports the multiple-dose container design, but it doesn't authorize unrestricted reuse or substitute for sterility controls.
The boundary must remain explicit. Research-laboratory reconstitution is sample preparation for in-vitro or other approved laboratory investigations. It isn't a protocol for clinical administration, and no container size should be interpreted as a human administration schedule.
Storage, Temperature, and Shelf Life
A receiving researcher should be able to verify a vial's storage status before it reaches the preparation bench. Pfizer Medical guidance places the unopened bacteriostatic vial at 20 to 25°C, or 68 to 77°F, consistent with controlled-room-temperature handling, and identifies the 30 mL plastic flip-top format in its labeling (Pfizer Medical storage guidance). Protect the vial from light and follow the manufacturer's exact storage instructions.
The first puncture creates a separate control point. After opening, the vial should be refrigerated and discarded 30 days after first puncture, even if liquid remains, according to the same product guidance. The sealed-vial expiration date does not replace the post-puncture discard date. Record both in the inventory system.
Make the in-use date visible
Label each vial with its first-puncture date, calculated discard date, lot number, and responsible technician. Record any temporary temperature excursion as well. The printed storage statement does not remove the need to assess handling deviations.
Before every withdrawal, disinfect the stopper with sterile 70% isopropyl alcohol and allow it to dry. Use suitable sterile equipment, then return the vial to its designated storage condition. Do not leave it on an uncontrolled bench between preparation events.
The preservative system supports the labeled multi-dose period. It does not permit indefinite use or compensate for poor technique, a damaged closure, or an unknown storage history. Quarantine a vial with a broken crimp, compromised stopper, unexpected particles, or no traceable opening date.
A clear liquid is not proof of sterility. Appearance, storage history, in-use dating, and lot documentation must agree before a vial enters a preparation workflow.
The 30-day rule creates a planning gap for intermittent studies. A laboratory may still have substantial volume when the discard date arrives, yet that remainder cannot be carried into a new work period. Before opening a 30 mL vial, compare the planned withdrawal schedule with the allowed in-use period, and document enough detail to verify which batch was used for each preparation. Procurement should consider projected draws and opening frequency, not only nominal fill or price.
How 30 mL Compares to Other Vial Formats
A study scheduled for occasional preparation can open a 30 mL vial, use only part of it, and still reach the discard date with liquid remaining. Format selection therefore starts with the withdrawal schedule, not the nominal fill. Estimate the number of preparation events, the volume used at each event, and the losses introduced by transfers and aseptic handling.
A 10 mL vial may suit a short experiment with few preparation events and can limit unused remainder. A 20 mL presentation fits an intermediate schedule. The 30 mL format supports more small withdrawals, provided they occur within the labeled in-use period. Pharmacy bulk containers between 50 and 100 mL may leave more residual material when the study cannot consume the full volume in time. Larger packaging is not automatically more efficient.
Compare by workflow, not by fill alone
Use the table as a planning tool. “Estimated draws” is a working estimate, not a guaranteed yield. The practical count changes with aliquot size, dead volume, transfer losses, stopper access, and the laboratory's aseptic process.
| Format | Typical Fill | Estimated Draws | Best-Fit Workflow |
|---|---|---|---|
| Small vial | 10 mL | Fewer small-volume withdrawals than a 30 mL vial | Short studies or low-frequency preparation |
| Intermediate vial | 20 mL | Moderate withdrawal count | Repeated work with a controlled, smaller batch |
| Multi-dose vial | 30 mL | Roughly twenty to twenty-five 1 mL withdrawals, subject to handling losses | Repeated small-volume research preparation |
| Bulk bottle | 50 to 100 mL | Potentially more withdrawals, with greater residual risk if the schedule is limited | High-throughput workflows with documented consumption planning |
The discard rule changes the calculation. A 30 mL vial does not provide thirty guaranteed 1 mL draws, because each puncture can introduce handling loss and the remaining volume may be unusable after the permitted in-use period. Record planned draw dates before opening the vial, then compare the final scheduled event with that discard date.
Preserved and non-preserved water also require separate evaluation. Equal fill volumes do not make the products interchangeable. Formulation and labeling determine whether repeated access is permitted under the product's stated conditions.
A laboratory running several small preparations during a compact study period may match well with 30 mL. Sporadic work may create less waste with a smaller presentation, if the selected product fits the method. Procurement teams reviewing research peptide laboratory products should compare batch records, compatibility, storage requirements, and projected draws, rather than package size alone.
Documentation and Batch Quality Checks
A 30 mL vial isn't bench-ready when it arrives. It becomes bench-ready after the physical container and the lot-specific records pass a defined release check.
The Certificate of Analysis should identify the exact lot and report the attributes required by the applicable product specification. Depending on the product and supplier, the record may include assay, pH, benzyl alcohol content, particulate assessment, sterility information, and bacterial endotoxin results. The researcher shouldn't accept a generic certificate that can't be tied to the vial in hand.
Four records should agree
Identity and traceability: The vial label, packing slip, certificate, manufacturer, lot number, and expiration date should agree. A mismatch blocks release until the supplier resolves it.
Sterility evidence: The available sterility record should describe testing appropriate to the product and laboratory quality system, including the relevant USP <71> framework where applicable. A sterility claim without lot linkage is weak evidence for a specific container.
Endotoxin information: Bacterial endotoxin results should be reported in the supplier's stated units and assessed against an acceptance criterion appropriate to the intended research application. The record should identify the tested lot.
Physical inspection: The receiving researcher should inspect the crimp, flip-top cap, stopper, solution clarity, container condition, and visible particle status. Physical defects can't be corrected by a favorable certificate.
The laboratory should file the COA, sterility data, endotoxin record, receiving log, and any discrepancy correspondence together. A practical testing and verification resource can support procurement teams that are building a repeatable documentation process, but each institution should define its own release requirements.
Release gate: No lot-specific COA, no verified identity, or no acceptable container inspection means the vial stays quarantined.
This approach protects more than compliance. It preserves the connection between a prepared sample and the diluent that entered it. If an assay produces an unexpected result, the team can trace the preparation back to the water lot, opening date, technician, storage record, and source documentation.
Planning Around Multi-Dependent Handling
A 30 mL vial may look generous on the shelf, yet several preparations can consume its usable window before the planned work is finished. The planning problem is not only volume. It is the number of documented withdrawals that can occur before the post-puncture discard date, while preserving traceability and controlled handling.
Start with a preparation forecast. Estimate the diluent needed for each lyophilized material, count expected withdrawals, and include realistic transfer losses. Then compare the schedule with the 30-day post-puncture discard period identified in product handling guidance. If work will continue beyond that period, dividing the schedule between two unopened vials can preserve batch identity and avoid retaining an in-use container past its discard date.
Keep each withdrawal auditable
Use an aseptic checklist that is brief enough for routine work but detailed enough for review:
- Disinfect the septum: Apply sterile 70% isopropyl alcohol and let the surface dry before entry.
- Use sterile equipment: Assign single-use syringes or transfer devices to the approved preparation event.
- Protect the clean zone: If the vial contacts a non-clean surface or is otherwise compromised, quarantine or retire it under the laboratory quality system.
- Record the event: Log the lot number, withdrawal date, technician initials, purpose, and remaining volume.
- Close the chain: File the preparation record with the compound lot, diluent lot, and resulting sample identifier.
A volume estimate alone cannot establish capacity. The vial may hold enough liquid for the remaining preparations, but an unknown opening date, incomplete storage record, or handling outside the controlled area can make further use unacceptable.
Treat the 30 mL presentation as part of batch design. Procurement, receiving, preparation, and disposal records should carry the same lot identity. This documentation shows how many draws the vial supported, what entered each preparation, when it entered, who handled it, and why the container was released or discarded.
Pro Tec Pep supplies research-use-only compounds and related laboratory materials, with batch-specific documentation and testing information for traceable workflows. Researchers evaluating bacteriostatic water 30ml alongside study materials can visit Pro Tec Pep to review its research catalog, documentation, and fulfillment options.
